These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 33238112)

  • 1. Endosomal Dysfunction Induced by Directly Overactivating Rab5 Recapitulates Prodromal and Neurodegenerative Features of Alzheimer's Disease.
    Pensalfini A; Kim S; Subbanna S; Bleiwas C; Goulbourne CN; Stavrides PH; Jiang Y; Lee JH; Darji S; Pawlik M; Huo C; Peddy J; Berg MJ; Smiley JF; Basavarajappa BS; Nixon RA
    Cell Rep; 2020 Nov; 33(8):108420. PubMed ID: 33238112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease.
    Kim S; Sato Y; Mohan PS; Peterhoff C; Pensalfini A; Rigoglioso A; Jiang Y; Nixon RA
    Mol Psychiatry; 2016 May; 21(5):707-16. PubMed ID: 26194181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased neuronal expression of the early endosomal adaptor APPL1 leads to endosomal and synaptic dysfunction with cholinergic neurodegeneration.
    Jiang Y; Sachdeva K; Goulbourne CN; Berg MJ; Peddy J; Stavrides PH; Pensalfini A; Pawlik M; Whyte L; Balapal BS; Shivakumar S; Bleiwas C; Smiley JF; Mathews PM; Nixon RA
    bioRxiv; 2024 Sep; ():. PubMed ID: 39345644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rab5-stimulated up-regulation of the endocytic pathway increases intracellular beta-cleaved amyloid precursor protein carboxyl-terminal fragment levels and Abeta production.
    Grbovic OM; Mathews PM; Jiang Y; Schmidt SD; Dinakar R; Summers-Terio NB; Ceresa BP; Nixon RA; Cataldo AM
    J Biol Chem; 2003 Aug; 278(33):31261-8. PubMed ID: 12761223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease.
    Shen R; Zhao X; He L; Ding Y; Xu W; Lin S; Fang S; Yang W; Sung K; Spencer B; Rissman RA; Lei M; Ding J; Wu C
    Transl Neurodegener; 2020 Jun; 9(1):26. PubMed ID: 32552912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration.
    Xu W; Weissmiller AM; White JA; Fang F; Wang X; Wu Y; Pearn ML; Zhao X; Sawa M; Chen S; Gunawardena S; Ding J; Mobley WC; Wu C
    J Clin Invest; 2016 May; 126(5):1815-33. PubMed ID: 27064279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing Rab5 Activation in Health and Disease.
    Pensalfini A; Jiang Y; Kim S; Nixon RA
    Methods Mol Biol; 2021; 2293():273-294. PubMed ID: 34453725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome.
    Cataldo AM; Petanceska S; Peterhoff CM; Terio NB; Epstein CJ; Villar A; Carlson EJ; Staufenbiel M; Nixon RA
    J Neurosci; 2003 Jul; 23(17):6788-92. PubMed ID: 12890772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ.
    Kwart D; Gregg A; Scheckel C; Murphy EA; Paquet D; Duffield M; Fak J; Olsen O; Darnell RB; Tessier-Lavigne M
    Neuron; 2019 Oct; 104(2):256-270.e5. PubMed ID: 31416668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ulk1 Governs Nerve Growth Factor/TrkA Signaling by Mediating Rab5 GTPase Activation in Porcine Hemagglutinating Encephalomyelitis Virus-Induced Neurodegenerative Disorders.
    Li Z; Zhao K; Lv X; Lan Y; Hu S; Shi J; Guan J; Yang Y; Lu H; He H; Gao F; He W
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29875237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression.
    Ginsberg SD; Alldred MJ; Counts SE; Cataldo AM; Neve RL; Jiang Y; Wuu J; Chao MV; Mufson EJ; Nixon RA; Che S
    Biol Psychiatry; 2010 Nov; 68(10):885-93. PubMed ID: 20655510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease.
    Nixon RA
    FASEB J; 2017 Jul; 31(7):2729-2743. PubMed ID: 28663518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99).
    Jiang Y; Sato Y; Im E; Berg M; Bordi M; Darji S; Kumar A; Mohan PS; Bandyopadhyay U; Diaz A; Cuervo AM; Nixon RA
    J Neurosci; 2019 Jul; 39(27):5255-5268. PubMed ID: 31043483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rab5 mediates an amyloid precursor protein signaling pathway that leads to apoptosis.
    Laifenfeld D; Patzek LJ; McPhie DL; Chen Y; Levites Y; Cataldo AM; Neve RL
    J Neurosci; 2007 Jul; 27(27):7141-53. PubMed ID: 17611268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of Rab5-mediated endocytic pathways in Alzheimer's disease.
    Xu W; Fang F; Ding J; Wu C
    Traffic; 2018 Apr; 19(4):253-262. PubMed ID: 29314494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
    Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
    Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the potential role of rab5 protein in endo-lysosomal impairment in Alzheimer's disease.
    Behl T; Kaur D; Sehgal A; Singh S; Makeen HA; Albratty M; Abdellatif AAH; Dachani SR; Bungau S
    Biomed Pharmacother; 2022 Apr; 148():112773. PubMed ID: 35245734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing the Survival of a Neuronal Model of Alzheimer's Disease Using Docosahexaenoic Acid, Restoring Endolysosomal Functioning by Modifying the Interactions between the Membrane Proteins C99 and Rab5.
    Vigier M; Uriot M; Djelti-Delbarba F; Claudepierre T; El Hajj A; Yen FT; Oster T; Malaplate C
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 38999927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defects.
    Cataldo AM; Mathews PM; Boiteau AB; Hassinger LC; Peterhoff CM; Jiang Y; Mullaney K; Neve RL; Gruenberg J; Nixon RA
    Am J Pathol; 2008 Aug; 173(2):370-84. PubMed ID: 18535180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cGMP favors the interaction between APP and BACE1 by inhibiting Rab5 GTPase activity.
    Caudano F; Montalto G; Passalacqua M; Pronzato MA; Fedele E; Ricciarelli R
    Sci Rep; 2020 Jan; 10(1):1358. PubMed ID: 31992816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.